ARR of SEK 14.3m, up 52% y-o-y in Q1'23 Costs kept up with revenue growth We trim '23e EBITDA to SEK...
Redeye comments on Evaxion's Q4 report for 2022. There has been a strategic realignment since Per No...
Redeye thinks today's proposal from FCC is indeed an important step to boost customer launches in th...
Decent Q1, continuing to improve margins y-o-y '23e-'25e adj.
Tuff start på 2023 men aktiviteten är hög och rörliga volymer återhämtas.
Redeye looks beyond the soft result in Q1 and starts looking forward to the strong pipeline of games...
Q1: 31% organic sales growth and EBITA margin doubling We raise estimates on further signs of profit...
Hansa has established a research and development collaboration with French Genenthon based on the ca...
Redeye returns with a more detailed take on Sedana Medical’s Q1 report, and we see signs of improved...
Redeye gives an updated view on Gapwaves after its Q1'23 report.
Bra tillväxt i en utmanande miljö Bokusgruppen rapporterade ett starkt resultat givet de utmaningar ...
Kvartalet i korthet Omsättningen uppgick till 13,0 mkr (4,2) och rörelseresultatet uppgick till -14,...
Förlängd finansiering Vi överraskades av bolagets fina kostnadskontroll i Q1’23 och att rörelsekostn...
Orderingången över 600 mkr för femte kvartalet i rad Kvartalet präglades av en hög nivå av marknadsa...
Starkaste första kvartalet i historien Orderingången i första kvartalet uppgick till 57,7 mkr, vilke...
Redeye communicates some pros and cons in this initial comment to the announcement of a rights issue...
SRV’s revenue declined clearly in Q1, as residential construction volumes were low, and profitabilit...
Dovre’s Norwegian operations drove Q1 EBIT above our estimate even when there was an FX headwind and...
Loihde’s Q1 result came in below expectations. While net sales increased by 13%, adj.
CapMan's net sales in Q1 amounted to EUR 15.1m, below our estimates and below consensus (EUR 16.
